PACS Group, Inc.
PACS
Positions held
Your positionsPACS isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.
- PACS Group, Inc. operates in the healthcare sector, which is experiencing significant growth driven by an aging population and increasing demand for medical care facilities.
- The company's revenue for 2026-Q2 was $1.428 billion, showing a 1% increase compared to the previous quarter.
- PACS reported a net income of $76.37 million in 2026-Q2, reflecting a strong earnings growth of 51.6% year-over-year.
- Despite the growth potential, PACS has a high debt-to-equity ratio of 305.265, indicating significant leverage and financial risk.
- The gross margin decreased to 17.1% in 2026-Q2 from 17.6% in the prior quarter, suggesting potential cost pressures.
- The overall score for PACS is a 'Sell' with a score of -5.00, indicating bearish sentiment based on recent trends.
Fundamentals
| Market cap | $6.92B | Enterprise value | $10.17B | Trailing P/E | 25.28 | Forward P/E | 16.01 |
| PEG | 1.09 | Price / book | 6.24 | Beta | -0.08 | Dividend yield | 0.00% |
| Revenue growth | 9.1% | Earnings growth | 51.6% | Gross margin | 17.3% | Operating margin | 7.7% |
| Profit margin | 4.8% | ROE | 27.9% | ROA | 4.6% | Debt / equity | 3.05 |
| Current ratio | 0.91 | Free cash flow | $378.32M | Analyst recommendation | strong_buy | Mean target | $59.00 |
| 52w high | $49.49 | 52w low | $10.31 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $1.4B | $1.4B | $1.4B | $1.3B | $1.3B | — |
| Op margin | 7.7% | 8.5% | 7.0% | 6.4% | 6.1% | — |
| Net income | $76.4M | $80.7M | $59.7M | $52.4M | $51.0M | — |
| Gross margin | 17.1% | 17.6% | 16.5% | 15.1% | 14.8% | — |
| Gross profit | $244M | $250M | $224M | $203M | $194M | — |
| Operating income | $109M | $120M | $94.7M | $86.3M | $80.5M | — |
- Revenue +1% vs prior quarter ($1.4B vs $1.4B).
- Gross margin 17.1% (was 17.6% prior quarter).
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $5.3B | $4.1B | $3.1B | $2.4B |
| Op margin | 5.9% | 3.0% | 6.7% | 9.5% |
| Net income | $192M | $55.8M | $113M | $150M |
| Gross margin | 14.8% | 12.4% | 14.4% | 16.5% |
| Gross profit | $780M | $508M | $447M | $401M |
| Operating income | $310M | $123M | $208M | $229M |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-07 · Is PACS Group (PACS) Cheap On Its Florida Nursing Home Expansion?
2026-10-06 · PACS Group Insider Sold Shares Worth $3,499,286, According to a Recent SEC Filing
2026-10-05 · Omega to Transition Operations of 32 Facilities in Florida to PACS Group
2026-09-30 · Seventeen PACS Post-Acute Locations Named Top Nursing Homes for 2027 by Newsweek Magazine
2026-09-21 · PACS Names Patrick Murphy Chief Legal Officer Following John Mitchell's Retirement
2026-09-21 · PACS Group Announces Chief Legal Officer Transition
2026-09-18 · PACS Group Insider Sold Shares Worth $1,725,133, According to a Recent SEC Filing
2026-09-14 · PACS Group, Inc. to Present at the 2026 Jefferies Healthcare Services and Technology Conference on September 15, 2026
2026-09-09 · Pacs Group Insider Sold Shares Worth $2,237,373, According to a Recent SEC Filing
2026-09-08 · PACS Expands Florida Footprint With 32-Facility Acquisition
2026-09-04 · PACS Group Insider Sold Shares Worth $2,903,753, According to a Recent SEC Filing
2026-09-02 · PACS' Florida Deal Supports Market Expansion, UBS Says
Price (daily)
Full chart · RSI · MACD · patterns